A Multicenter, Open-Label, Single-dose, Pharmacokinetic and Safety Study of Dexpramipexole (BIIB050) in Healthy Subjects and Subjects With Renal Impairment.
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2014
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Pharmacokinetics
- Sponsors Knopp Biosciences
- 27 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 27 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2011 New trial record